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Abstract-This paper describes the Data Registry System of the Cystic Fibrosis Foundation. 
Through this system an annual up-dated and corrected data base has been prepared for 
cystic fibrosis patients seen at U.S.A. Centers from 1966 through 1972. 
From the data base, a large number of life table studies are calculated. A study is specified 
by its data base, the observation period, analysis year (age year or year since diagnosis), the 
Centers included, and the condition of patients at birth, and possible additional factors such 
as sex, age at diagnosis, or race. The annual rates of mortality are measured by a force of 
mortality technique. 
Two techniques have been used to appraise the mortality of particular groups, graphing 
the cumulative survival function for the group together with the cumulative survival function 
for a comparison group, and calculation of mortality ratios of actual to expected deaths (by 
an applicable standard mortality table). This latter approach lends itself readily to tests of 
significance. 
For the purpose of calculating mortality ratios, two standard tables have been prepared 
on the basis of the 1972 Data Base and the 19661972 observations. The first of these 
standard tables is for use with age year studies, and the second is for years since diagnosis 
studies. 
The paper comments on a number of mortality studies by calendar year, by sex, by con- 
dition at birth, by age at diagnosis, and of survival from diagnosis of patients diagnosed in 
19664972. The calendar year studies indicate an improvement trend in the survival ex- 
perience from 1966 to 1972 but a change may be occurring. The study by sex exhibits a higher 
female mortality. The 7% of patients who have meconium ileus at birth show a significantly 
higher first-year mortality, and a somewhat lower survival rate thereafter even if the first 
year of life experience is excluded. Mortality data for groups specified by age at diagnosis 
are given. For patients diagnosed during 1966-1972, there is some indication of better 
survival than for patients diagnosed prior to 1966. 
The continuation of these. mortality studies on an annual basis should further our under- 
standing of survival patterns for cystic fibrosis patients. 
IN THE United States over the last 30 yr, the survival of patients with cystic fibrosis has 
dramatically improved under proper care from a very poor prognosis to an average 
lifetime of approximately 20 yr, with continuing improvement anticipated. Warwick 
and Pogue have documented this improvement in survival by means of life table 
studies for a number of years [l]. They have developed a computerized, continuous 
investigation of the mortality of the children and young adults seen at Cystic Fibrosis 
Centers throughout the United States supported by the Cystic Fibrosis Foundation 
(CFF) [2]. From U.S. Centers they receive annual reports on approximately 9000 
cystic fibrosis patients, and at the end of 1972 had an aggregate of 15,000 individual 
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reports on patients seen at the Centers during 1966-1972. They are also receiving data 
from other countries, for instance, they have 1400 reports on Canadian patients. Life 
table studies, on various bases have been compiled annually from these reports. 
Recently a Data Registry Committee has been appointed to review and extend the 
work of Warwick and Pogue.* Under the auspices of this Committee the last two 
authors, who are actuarial mathematicians, have been working with the first two 
on the further development of the continuous mortality investigation of cystic fibrosis 
patients. 
The CFF Data Registry is recording the mortality experience of patients seen at 
Cystic Fibrosis Centers and is permitting the observation of trends and variations. 
In our view, the historical record of progress in improving the survival of cystic fibrosis 
patients is a valuable end in itself. But information and observations emerging from 
the Data Registry can also assist patients in fulfilling their lives, and can provide 
direction to the CFF and other organizations concerned with diminishing this genetic 
disease. Successful development and utilization of the Cystic Fibrosis Data Registry 
may well provide a model for use with other diseases of genetic origin. 
This paper outlines data collection and management, summarizes the data and 
describes the methodology of life table studies based thereon, includes tables and 
figures documenting the mortality experience in the calendar years 19661972, and 
concludes with the major trends observed. 
COLLECTION AND MANAGEMENT OF THE DATA 
All Cystic Fibrosis Centers supported by the Foundation are required to provide an 
annual report on every patient with cystic fibrosis seen by that Center during the pre- 
ceding year. For new patients, the Center reports the initials of his name; city, state, 
and zip code of residence; date of birth; date of diagnosis; sex; type of birth (single or 
multiple); race; condition at birth (normal, with meconium ileus, or with intestinal 
obstruction); and the patient’s status at the end of the year. For previously reported 
patients, the Center reports only his status at the end of the year. If the patient has 
died, the Center reports also the date of death and the cause of death. Figure 1 shows 
the current Cystic Fibrosis Data Registry Annual Report Form. It requires minimal 
effort to report on this form annually over a period of years. 
The reports are checked manually for completeness and correctness. They are then 
read by an optical scanner onto a magnetic tape which forms the initial data base for 
the latest completed calendar year, in this paper 1972. The data base is computer- 
edited for completeness and consistency; for example, an inconsistency such as a child 
diagnosed before the reported date of birth will be identified. A listing of patients with 
missing or inconsistent information is tabulated. To the extent feasible these data 
problems are resolved and the initial data base is corrected. The corrected initial 1972 
data base is then augmented by data on patients included in the 1971 data base but who 
are not reported for 1972 because of death, transfer, or lost to follow-up in prior years, 
or other reason. This provides the final data base, inclusive of data for calendar years 
1966-1972, and is referred to as the 1972 Data Base. It is the up-dated basis for case 
load analyses and life table studies. 
*This is a committee of the General Medical and Scientific Advisory Council of CFF and consists of 
Michael B. Gregg (Center for Disease Control); Richard E. Pogue (Medical College of Georgia): 
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report for the patient beyond 1969, an overlapping of mortality data may occur. The 
extent of such duplication of mortality data has been examined twice. In 1968, 
Warwick and Pogue estimated that there was concurrent reporting by more than one 
Center of the same patient in approximately 2% of the total reports. In 1974, Warwick 
and Pogue ran a second test which showed up 153 cases as possible inter-center 
duplicates. This is approximately 1.5% of the total cases reported by U.S.A. Centers 
for 1973 and would have minor effect on national mortality studies. 
The Data Registry System has a continuous adjustment process built into it. An 
incomplete, inconsistent or not-submitted report that could not be included in the 
1971 Data Base may be corrected and included in the 1972 Data Base. The report will 
thereupon be a datum for studies utilizing the 1972 Data Base, in particular, it may be 
a datum for study of 1971 mortality by means of the 1972 Data Base. 
SUMMARY OF THE DATA 
A summary of the 1972 Data Base is given in Table 1. As indicated earlier, the 1972 
Data Base contains all individual reports for the period 1966-1972, and may include 
TABLE 1. SUMMARY OF 1972 DATABASE 
Total number of individual reports 








Other, or not stated 



















Distribution by condition at birth: 
Meconium ileus 1,045 
Intestinal obstruction 198 
Normal 13,196 
Not stated 775 
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TABLE 2. ANALYSIS OFCASES REPORTEDFOR 1972~~ U.S.A.CENTEW 
(COMF’UTED FROMTIiE1972DATABASE) 
Number of Centers 
reporting for year 97 
Patients reported 
under care at' 









returned to care 
Minus 
Patients not reported 
on for 1972, and reports 
held for correction 












Transfers to Other 





alive and under care 





reports from two Centers on a single patient who has transferred from one Center to 
another. This duplication affects the number of reports but should have minor effect 
on percentage distributions. From Table 1 one can observe that male patients are 
more prevalent than females, 52.3 vs 47.7%. As will be seen later, a contributing 
factor is the more favorable survival of cystic fibrosis males in comparison with that 
for females. The bulk of the patients, 96.8% are Caucasian; only 1.5% are negroid. 
Identical twins, fraternal twins and other multiple births account for a normal pro- 
portion of pIural births (approximately 2%). Meconium ileus appears as a birth 
complication for 7.2% of the patients for which condition at birth was stated. 
In Table 2 the number of U.S.A. Centers reporting for 1972 is indicated, and an 
analysis of the cases reported for 1972 is presented. The number of reporting Centers 
has increased from 53 in 1966 to 97 in 1972, and the total number of cases reported 
on for a year has gone from 5288 for 1966 to 9019 for 1972. 
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The annual number of new diagnoses at U.S.A. Centers has increased from 598 in 
1966 to 720 in 1972 but during that 7-yr period the number of Centers has increased, 
and the total number of births in the U.S.A. has decreased from 3,606,OOO to 3,256,OOO. 
A considerable number of the patients first reported for a year have been diagnosed 
prior to the year of reporting, and there were 512 such reports in 1972. 
At year end, a Center will report whether a patient is still under care, has died during 
the year, has transferred to another Center or to a local M.D., or has been lost to 
follow-up. In some doubtful cases the Center may not report the patient’s year-end 
status. Meanwhile the patient may have been seen at another Center and will be re- 
ported by the new Center. There may be some incompleteness and inaccuracy in the 
reports from individual Centers, and Table 2 may exaggerate the in and out movement 
of patients, but under the continuous correction procedures of the system the aggregate 
data is a reasonably valid basis for mortality studies. 
The 326 deaths reported for 1972, and the beginning and year-end totals of 8200 
and 8149 patients alive and under care, imply a crude death rate of 4%. 
METHODOLOGY OF LIFE TABLE STUDIES 
Specifications of life table studies 
A first specification of a life table study is the Data Base. Normally, the patient data 
in the latest available Data Base is sorted into various groups in order to make parti- 
cular life table studies. A next specification for a study is the observation period. Two 
types of studies have been made-longitudinal and cross-sectional. For longitudinal 
studies based on the 1972 Data Base, the observation period was taken to be all the 
years 1966-1972. Cross-sectional studies in contrast specify a single calendar year as 
the observation period. 
Most studies are for all Centers. Special longitudinal studies for individual Centers 
are carried out when sufficient data is available to provide meaningful results. 
Studies may be specified by selection from the reported data, for example, condition 
at birth: some studies include all conditions at birth, some are limited to patients with 
normal birth, some to those who had meconium ileus or to those with intestinal 
obstruction. Most studies are done in respect to normal birth or on all conditions at 
birth because the data on meconium ileus and intestinal obstruction cases is too sparse. 
Two choices for analysis year have been indicated in earlier studies-analysis by age 
year in [I], [2] and analysis by years since diagnosis [2], [3]. We are using both types 
of analysis as each may provide useful information, and we are not prepared to discard 
one in favor of the other. 
Other specifications for life table studies are sex, race, age at diagnosis, and zip code 
region. For most of the longitudinal and cross-sectional studies, these factors are com- 
bined rather than specified, but special studies specifying one or more of the foregoing 
factors are done each year. 
Estimation of rates 
The immediate objectives of a life table study are the estimation of yearly death 
rates and the calculation of cumulative survival rates therefrom. For studies on the 
1972 Data Basis we decided to use the ‘force of mortality’ technique [4] which utilizes 
an easily understood concept of patient-years of exposure. The ‘force of mortality’ at 
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a given moment of age is the annual rate of mortality operating for that instant of age. 
It implies a continuous decrease (negative growth) for the life table cohorts in contrast 
to the usual mortality rate q, which operates on a discrete year of age rather than on 
a continuous basis. The average force of mortality cl, for the year of age x to x+1 is 
related to the (discrete) rate of mortality q, by the exponential formula 
qy= 1 --exP [-F,l 
(where exp denotes the exponential function, i.e. exp y=eJ’). 
Mortality appraisal, standard tables 
One approach to appraising the mortality of a particular group is to graph the 
cumulative survival function for that group together with the cumulative survival 
function for a comparison group. For example, one could compare the graph of the 
subgroup of patients with normal births with the graph for the combined group of all 
patients. This gives a quick visual comparison which is often adequate for the purpose 
on hand. 
Another approach, widely used by actuaries, is to establish an appropriate basic or 
standard table of mortality rates, and by applying these standard rates to the patient- 
years of exposure in each analysis year for the group under study obtain the number 
of expected deaths for the group. The ratio of actual deaths to expected deaths is 
used as an index of the mortality of the group and is referred to as the mortality ratio. 
A 1966-1972 Standard Table for Age Year Studies of Cystic Fibrosis Mortality has 
been prepared from the life table study with the following specifications: 
Data base - 
Observation period - 
Analysis year - 
Centers included - 




All U.S.A. Centers 
Normal 
Table 3 contains at selected ages the exposures, deaths, estimated annual rates 4% of 
mortality, and cumulative survival rates i(x) for this study together with annual rates 
of mortality q, and cumulative survival rates S(X) for the 1966-1972 Standard Table 
for Age Year Studies. A minimum of smoothing was used to replace the observed 
average annual forces of mortality by standardized average annual forces lying on a 
series of linear segments. The latter were obtained by joining points representing the 
average forces of mortality for age-groups O-l, 1-4, 4-7, 7-10, 10-13, 13-16, 16 and 
above. This was considered to be a slight but sufficient improvement over simply 
using the weighted average forces as constant forces over the age-groups for the pur- 
pose of calculating expected deaths. Thereby, the force of mortality is represented by 
a continuous curve rather than by a set of steps. 
A 1966-1972 Standard Table for Years since Diagnosis Studies of Cystic Fibrosis 
Mortality was also prepared from a life table study with the same specifications as for 
the study underlying Table 3 with the sole exception that the analysis years were years 
since diagnosis rather than age years. Table 4 presents abridged details. 
The mortality and survival rates in Tables 3 and 4 are average rates for cystic fibrosis 
patients (with normal birth) seen at the Centers during 1966-1972. 
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CROSS-SECTIONAL STUDIES 
Each year various cross-sectional life studies are made on the basis of the latest 
data base. In 1973 such studies were made for each of the calendar years 1966-1972 
for all Centers combined. Each study shows for each analysis year the patient-years of 
exposure, the number of deaths, the annual mortality rate, and the cumulative survival 
rate, In Fig. 2, cumulative survival rates are graphed for a 1966 cross-sectional study, 
TABLE 3. UNDERLYING DATA AND BASIC FUNCTIONS FOR 19661972 STANDARD TABLE 
FOR AGE YEAR STUDIES 0~ CYSTIC FIBROSIS MORTALITY (TELEXED AGEX~) 
Age Year ’ 

















































. 0465 .668 
. 0553 .518 
. 0772 .378 
.1079 . 236 
.I377 .125 
a Full table may be obtained from the Cystic Fibrosis Foundation. 
b For force of mortality method. 
c Estimated annual rate of mortality for year x to x+ 1. 
&= 1 -exp[ -deaths/exposure] where exp denotes the exponential function. 
d ?(x)=cumulative survival rate from year 0 to year x. 
e Standard annual rates of mortality obtained by smoothing as indicated in text. 
TABLE 4. UNDERLYING DATA AND BASIC FCJN~TIONS FOR 1966-1972 STANDARD TABLE 
FOR YEARS SINCE DIAGNOSIS TUDIES 0F CYSTIC FIBROSIS MORTALITY (SELE~D AGES*) 











o-1 4159.1 143 .034 1.000 .0338 1.000 
5-6 3269.9 139 .042 . 841 .0433 .839 
10-11 1660.8 98 .057 . 649 .0558 -653 
15-16 563.7 44 .075 . 475 .0710 .475 
20-21 130.1 8 ,060 . 321 .0891 .319 
25-26 18.8 1 ,052 .176 .1194 -187 
30-31 1.5 0 0 .127 .1487 .092 
*See footnotes to Table 3. 
a 1972 cross-sectional study and a 1966-1972 longitudinal study (in all cases in terms 
of age years and on the basis of the 1972 Data Base for all U.S.A. Center patients who 
had ‘normal’ births, i.e. did not have meconium ileus or intestinal obstructions.) 
Figure 2 indicates that for the patients observed in these studies, the age for 50% 
survival has increased from 10.4 yr in 1966 to 18.1 yr in 1972, an average annual in- 
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- 1972 Cross-sectional 
***“* 1966-72 Longiludinoi 
-.- 1966 Cross-sectional 
0’ *I,,,,,,, I I I I I I I , I , I2 34 5 67 6 910 I2 14 16 16 20 22 24 26 26 30 
AGE IN YEARS 
FIG 2. Survival rates 1966-1972. Study specifications: 1972 data base, by age years, 
all U.S.A. Centers, normal birth. 
crease of over one year for each year of study. Because the 1972 survival curve is 
almost linear, the average years of future lifetime from birth is also approximately 
18 yr. 
Another measure of the mortality improvement over the 7-yr period is given in 
Fig. 3 which shows the ratios of actual deaths to expected deaths by the 1966-1972 
Standard Table for Age Year Studies (see Table 3). This study is on the 1973 Data 
Base because the corresponding figures on the 1972 Data Base were affected by a 
computer programming problem which slightly overstated deaths for some of the 
cross-sectional studies. Over the 7 yr there is a strong decreasing trend in the mortality 
ratios. However, the mortality ratio for 1973 has been calculated as 90%. If further 
135 I 
MORTALITY RATIOS 
(Actual Deaths/Expected Deathal x 100 
CALENDAR YEAR 
FIG. 3. Mortality ratios by calendar year. 
Study specifications-1973 data base; by age years; all U.S.A. Centers; normal birth; 
male-s and females combined. 
Expected deaths by 19661972 standard table for age year studies. 
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study confirms this upturn for 1973, it will remain to be seen whether this is a temp- 
orary fluctuation or reflects some underlying change, We plan to follow this matter 
closely in the coming years. 
LONGITUDINAL STUDIES - BY AGE YEARS 
Many of the specific groups of patients studied had too few members to permit 
useful studies to be made on a cross-sectional basis. For such groups, studies were 
longitudinal with observation period extending over the whole 7-yr period, 1966-l 972. 
Comments on a number of such studies are given the following. 
Sex 
Figure 4 shows survival rates observed over 1966-1972 for males and females com- 
bined, compared with the survival rates for males and females separately. At all ages 
11,,,,,1,,,, I , , , , , , 
o 
, , 
I 2 3 4 5 6 7 8 9 1011 I2 14 16 I6 20 22 24 26 26 30 
AGE 
FIG. 4. Survival rates by sex. Study specifications: 1972 data base; 19661972 longitudinal; 
by age years; all U.S.A. Centers; normal birth. 




Actual Expected Plortality 
Deaths Deaths Ratio 
o-1 29 40.2 72% 
1-7 187 255.4 73 
7-13 313 348.0 90 
13-19 205 239.9 85 
19+ 125 154.5 81 
Total 859 1038.0 83 
Females 
Actual Expected Mortality 
Deaths Deaths Ratio 
47 35.8 131%‘ 
311 248.7 125 
348 307.3 113 
212 178.5 119 
107 87.9 122 
1025 858.2 119 
Study specifications-1972 data base; 1966-1972 longitudinal by age years; all U.S.A. Centers; 
normal birth. 
Expected deaths by 1966-1972 standard table for age year studies of cystic fibrosis patients. 
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the survival of males is better than the survival of females, contrary to the usual relation 
between male and female mortality. This differential is shown another way by mort- 
ality ratios in Table 5. For each age group O-l, l-7 (pre-school), 7-13 (primary school), 
13-19 (secondary school), 19f (post high school), the mortality ratio for females is 
substantially higher than the mortality ratio for males. The accumulating data con- 
tinues to show this mortality differential between males and females. 
Conditions at birth 
Figure 5 shows the longitudinal survival curves for patients with the birth compli- 
cations of meconium ileus and intestinal obstruction, without distinction by sex. The 
total patient-years of exposure are small for the intestinal obstruction group (543) 
compared to the meconium ileus group (2945) and the normal birth group (40,491). 
Although much of the difference between the curves for the meconium ileus group and 
the normal group lies in the O-l yr mortality, even with this eliminated by calculation 
of survival curves from age 1, patients with meconium ileus appear to have a slightly 
poorer cumulative survival curve than do patients with normal birth. 
SURVIVAL FROM AGE 0 
- Normal Birth 
- .- intaslind Obslrucfion 
...‘.‘. Meconlum lIeus 
SURVIVAL FROM AGE 1 
2 4 6 6 IO 12 14 16 I 3 5 7 9 II 13 I5 17 
AGE 
FIO. 5. Survival rates by condition at birth. Study specifications: 1972 data base; 
1966-1972 longitudinal; by age years; all U.S.A. Centers. 
LONGITUDINAL STUDIES - BY YEARS SINCE DIAGNOSIS 
In the preceding studies, the analysis year has been the age year, with all years since 
diagnosis combined. In the following studies, the analysis years are years since diag- 
nosis with all ages combined. In the first subsection, studies of patients grouped by 
age at diagnosis are reported. 
Age at diagnosis 
In Table 6 are shown distributions of the patient-years of exposure and the deaths 
according to the age at diagnosis of the patients. The two distributions are remarkably 
similar, for instance, 42.4% of the patient-years of exposure and 41.7% of the deaths 
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TABLE 6. DL?ZRIBUTIONS OF EXPOSURES AND DEATHS BY AGE AT DIAGNOSIS 
Age. at 
Diagnosis 
x to x+1 
T Patient Years of Exposure for Patients Diagnosed Between Deaths of Patients Diagnosec Between Ages x and x+1 A !S x and x+1 
Total Percent 
O-l 17,139 42.4% 
l-2 5,733 14.2 
2-3 4,197 10.4 
3-4 2,739 6.8 
4-5 2,102 5.2 
5-6 1,780 4.4 
6-7 1,325 3.3 
7-8 1,063 2.6 
8-9 912 2.3 
9-10 583 1.4 















Total Percent Cumulative 
Percent 
780 41.1% 41.7% 
264 14.1 55.9 
177 9.5 65.3 
122 6.5 71.9 
104 5.6 77.4 
98 5.2 82.7 
62 3.3 86.0 
41 2.2 88.2 
40 2.1 90.3 
31 1.7 92.0 
150 8.0 100.0 
1,869 
Study specifications-1972 data base; 1966-1972 longitudinal by years since diagnosis; all U.S.A. 
Centers: normal birth. 
are in respect to patients who were diagnosed between ages 0 and 1, and 78.9% of the 
years of exposure and 77.4% of the deaths are for patients diagnosed before age 5. 
The mortality of patient groups specified by age at diagnosis is being studied but is 
not ready to be reported. It is established that the mortality is higher al the same time 
duration from diagnosis for patients diagnosed later in life than for the general body 
of patients (of whom approximately 80% are diagnosed below age 5). However, a 
patient who is diagnosed at say age 15 and is observed over the first 5 yr since diagnosis 
is much older than the average patient in the first 5 yr after diagnosis, and this factor 
may account for the observed higher mortality. We plan further study of this question. 
Patients diagnosed during 1966-1972 observation period 
The mortality data in Table 4 is in respect to all patients seen at CF Centers during 
19661972 irrespective of whether the patients were diagnosed prior to 1966 or during 
1966-1972. Data for the latter groups was separated out and survival from diagnosis 
was studied in comparison with the survival by years since diagnosis of all patients. 
For the group diagnosed during 1966-1972, experience can extend at most to the 
seventh year since diagnosis and, for comparison, only the experience of all patients 
during the first 7 yr since diagnosis should be used. The results are given in Table 7. 
Part (a) of this table shows mortality data, cumulative survival rates and expected 
deaths for the group of patients diagnosed during 1966-1972 while part (b) gives for 
comparison the corresponding items for all patients observed. 
The cumulative survival rates are close for the first 2 or 3 yr, a not unexpected result 























































































































































































































































































































































































































































































































































































































































































































































































































622 WARREN J. WARWICK et al. 
From year 3 onward, the experience of patients diagnosed prior to 1966 becomes a 
significant element for the part (b) statistics. One would hope that the experience for 
the more recently diagnosed patients would show some improvement over that for 
patients diagnosed prior to 1966, and there is some indication to this effect. For 
patients diagnosed during 1966-1972, the mortality ratio for years O-2 is 102.1% and 
for years 2-7 is 82.6%. On the assumption that actual deaths for years 2-7 is a Poisson 
random variable with parameter equal to the expected number of deaths for year 2-7, 
the probability of observing a mortality ratio<82.6% is less than 50/. 
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